| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology, The University of Michigan, School of Medicine, Ann Arbor, Michigan 48104
A study was done to define the conditions that had to be met to immunize C58 mice to line Ib transplantable leukemia (Ib cells). The relative immunogenicity of Ib cell preparations inactivated by a variety of methods was compared. Cell preparations were inactivated by exposure to UV light for up to 60 minutes. A cell concentration of 106 to 107 per ml exposed to UV light for 15 to 30 minutes was the most immunogenic. A dose of 105 cells per ml was only weakly immunogenic. A dose of 108 UV-irradiated cells killed all of the recipient mice. However, when 108 cells were exposed to 15,000 R of X-irradiation they were strongly immunogenic; a 105 cell dose exposed to 5,00015,000 R was not immunogenic. A preparation of 107 cells per ml exposed to 5,00015,000 R was the most immunogenic. The optimum method for inactivating cells with formalin was by exposure to a 1:500 dilution for 18 hours at 4°C. A dose of 107 cells per ml was the most immunogenic. Frozen-thawed, sonicated-lyophilized, and sonicated-filtered preparations were immunogenic, providing that the initial cell concentration was about 108 per ml and that the proper dose regimen was used for immunization. Freund's complete adjuvant impaired the immune response of C58 mice to UV-, X-irradiated, or formalin-treated cell preparations.
Quantitative studies of cell-associated immunity to line Ib leukemia were carried out. Immune lymphoid cells were obtained from the spleen, lymph nodes, and peritoneal cavity of immune C58 mice. A ratio of 10 immune cells to 1 Ib cell was necessary to afford complete protection. When mice were immunized by a single injection of formalinized or UV-inactivated cells, immunity persisted at a high level for approximately 1 year.
1 Supported by Grant 06639, National Cancer Institute, NIH, USPHS.
Received 9/20/67. Accepted 3/25/69.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |